These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 24150826)
1. [Spironolactone in dermatological treatment. On and off label indications]. Salavastru CM; Fritz K; Tiplica GS Hautarzt; 2013 Oct; 64(10):762-7. PubMed ID: 24150826 [TBL] [Abstract][Full Text] [Related]
2. [Off-label indications for topical tacrolimus]. Hengge UR Hautarzt; 2013 Oct; 64(10):752-6. PubMed ID: 24150824 [TBL] [Abstract][Full Text] [Related]
3. [Off-label use of infliximab]. Onder M; Salavastru C; Fritz K Hautarzt; 2013 Oct; 64(10):757-61. PubMed ID: 24150825 [TBL] [Abstract][Full Text] [Related]
4. [Off-label use]. Fritz K; Augustin M; John SM Hautarzt; 2013 Oct; 64(10):727. PubMed ID: 24150819 [No Abstract] [Full Text] [Related]
6. Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions. Chu S; Michelle L; Ekelem C; Sung CT; Rojek N; Mesinkovska NA Arch Dermatol Res; 2021 Aug; 313(6):391-430. PubMed ID: 33151346 [TBL] [Abstract][Full Text] [Related]
7. Use of spironolactone in dermatology. Rathnayake D; Sinclair R Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648 [TBL] [Abstract][Full Text] [Related]
8. Spironolactone in dermatology: uses in acne and beyond. Searle TN; Al-Niaimi F; Ali FR Clin Exp Dermatol; 2020 Dec; 45(8):986-993. PubMed ID: 32844462 [TBL] [Abstract][Full Text] [Related]
9. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism. Vargas-Mora P; Morgado-Carrasco D Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):639-649. PubMed ID: 32571540 [TBL] [Abstract][Full Text] [Related]
10. [Off-label use of alitretinoin]. Fritz K; Tiplica GS; Salavastru C; Onder M Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823 [TBL] [Abstract][Full Text] [Related]
12. Spironolactone in dermatology. Aguilar Medina DA; Cazarín J; Magaña M Dermatol Ther; 2022 May; 35(5):e15321. PubMed ID: 35038224 [TBL] [Abstract][Full Text] [Related]
13. Emulsions with alkyl polyglucosides as carriers for off-label topical spironolactone - safety and stability evaluation. Ilic D; Cvetkovic M; Tasic-Kostov M Pharm Dev Technol; 2021 Mar; 26(3):373-379. PubMed ID: 33428486 [TBL] [Abstract][Full Text] [Related]
14. Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile. Ganzetti G; Campanati A; Molinelli E; Offidani A Curr Drug Saf; 2016; 11(1):12-21. PubMed ID: 26463243 [TBL] [Abstract][Full Text] [Related]
15. A unique case of buffalo hump after prolonged use of spironolactone. Hudd TR; Chugh P; Zaiken K J Am Pharm Assoc (2003); 2018; 58(6):679-681. PubMed ID: 30219491 [No Abstract] [Full Text] [Related]
16. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Brown J; Farquhar C; Lee O; Toomath R; Jepson RG Cochrane Database Syst Rev; 2009 Apr; (2):CD000194. PubMed ID: 19370553 [TBL] [Abstract][Full Text] [Related]
17. Oral Metformin for Treating Dermatological Diseases: A Systematic Review. Sung CT; Chao T; Lee A; Foulad DP; Choi F; Juhasz M; Dobry A; Mesinkovska NA J Drugs Dermatol; 2020 Aug; 19(8):713-720. PubMed ID: 32845585 [TBL] [Abstract][Full Text] [Related]
19. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Farquhar C; Lee O; Toomath R; Jepson R Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916 [TBL] [Abstract][Full Text] [Related]